on BIOMERIEUX (EPA:BIM)
BioMérieux Introduces Advanced Equine Respiratory Disease Testing
bioMérieux has launched VETFIRE™, a novel PCR kit aimed at enhancing the diagnosis of equine infectious respiratory diseases. This innovative test is designed to deliver accurate results within 20 minutes, providing a crucial tool for equine veterinarians.
The launch comes in response to the significant concerns faced by the equine industry following past respiratory disease outbreaks. VETFIRE™ is equipped to detect seven respiratory pathogens in horses. It supports swift decision-making in treatment and management, crucial for maintaining animal health.
The test, processed via the BIOFIRE® SPOTFIRE® System, is available in the UK, Ireland, and France, with further availability expected. By distinguishing between viral and bacterial infections, the test aids in antibiotic stewardship, ensuring appropriate use of antibiotics.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOMERIEUX news